Mycomed Technologies, LLC

HALETHORPE, MD 21227

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $1.39MM
First Award Date 02/01/15
Most Recent Award Date 07/18/17

Key Personnel

Last Name Name Awards Contact
MARR KIEREN A. MARR 2
Shallcross MaryAnn Shallcross 2 Message

3 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 07/18/17 - 06/30/18

Invasive aspergillosis (IA) continues to cause morbidity and death in medically immune compromised patients, largely because we lack sensitive diagnostic tests that are easy to use during high-risk periods. We discovered that fungal galactofuranose?containing antigens are excreted in urine of infected animals and people, using a novel monoclonal...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BM
Budget: 07/01/15 - 06/30/16

The broader commercial potential of this Small Business Innovation Research (SBIR) Phase I project is for the early detection of aspergillosis, a severe fungal infection that most frequently involves the lungs in immune compromised individuals, typically as a result of cancer chemotherapy or transplantation. The disease is often misdiagnosed res...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 02/01/15 - 01/31/16

DESCRIPTION (provided by applicant): Aspergillosis is a severe fungal infection that most frequently involves the lungs in people who have immune deficiency caused by cancer chemotherapy and/or transplantation. Although good drugs are available, establishing a diagnosis is difficult, and late treatment has limited our progress in decreasing morb...